SOMATIC PAIN THRESHOLD AND REACTIVE HYPEREMIA IN AUTONOMIC DIABETIC NEUROPATHY AND SILENT-MYOCARDIAL-ISCHEMIA

被引:6
|
作者
HARTMANN, A [1 ]
SCHLOTTOG, B [1 ]
JUNGMANN, E [1 ]
BOHM, BO [1 ]
USADEL, KH [1 ]
KALTENBACH, M [1 ]
机构
[1] J W GOETHE UNIV,MED CTR,DEPT ENDOCRINOL,DIV INTERNAL MED,W-6000 FRANKFURT,GERMANY
关键词
SILENT MYOCARDIAL ISCHEMIA; AUTONOMIC DIABETIC NEUROPATHY; CORONARY ARTERY DISEASE; PAIN THRESHOLD;
D O I
10.1016/0167-5273(93)90081-Q
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In 31 patients with coronary artery disease (autonomic neuropathy, n = 11; diabetes without neuropathy, n = 10; silent myocardial ischemia without diabetes, n = 10) difference in somatic pain threshold and plethysmographically determined reactive hyperemia induced by forearm skeletal muscle ischemia was investigated. There was no difference in reactive hyperemia after passive maximum forearm ischemia in the three groups indicating identical vascular reactivity. After symptom-limited ischemic work however, reactive hyperemia was significantly higher in patients with silent myocardial ischemia as compared to diabetic patients. Exercise time was longer in patients with silent myocardial ischemia (153 +/- 51 s) as in patients with diabetic neuropathy (139 +/- 45 s) and diabetics without neuropathy (120 +/- 45 s). Pain as a cause of termination of symptom-limited ischemic forearm exercise occurred less frequently in patients with diabetic neuropathy (2/11) and patients with silent myocardial ischemia (3/10) as compared to patients with diabetes without neuropathy (9/10). In conclusion, patients with silent myocardial ischemia have a higher ischemic tolerance in the working forearm as compared to diabetic patients with and without neuropathy. There is a quantitative difference in ischemic tolerance between patients with silent myocardial ischemia and patients with diabetic neuropathy.
引用
收藏
页码:121 / 127
页数:7
相关论文
共 50 条
  • [41] CURRENT CONCEPTS OF SILENT-MYOCARDIAL-ISCHEMIA
    BLESKE, BE
    SHEA, MJ
    [J]. CLINICAL PHARMACY, 1990, 9 (05): : 339 - 357
  • [42] SILENT-MYOCARDIAL-ISCHEMIA AND CARDIOPROTECTION - FOREWORD
    BERTRAND, ME
    [J]. ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1993, 86 : 7 - 9
  • [43] LIPOPROTEIN(A) AND SILENT-MYOCARDIAL-ISCHEMIA IN IDDM
    HEGELE, RA
    CONNELLY, PW
    ARMSTRONG, PW
    LANGER, A
    [J]. DIABETES CARE, 1994, 17 (11) : 1365 - 1367
  • [44] LEFT-VENTRICLE MASS AND SILENT-MYOCARDIAL-ISCHEMIA IN DIABETIC SUBJECTS
    VALENSI, P
    SACHS, RN
    LORMEAU, B
    TAUPIN, JM
    METZ, D
    NITENBERG, A
    LEUTENEGER, M
    ATTALI, JR
    [J]. DIABETES, 1994, 43 : A198 - A198
  • [45] AUTONOMIC DYSFUNCTION AND SILENT-MYOCARDIAL-ISCHEMIA ON EXERCISE TESTING IN DIABETES-MELLITUS
    MURRAY, DP
    OBRIEN, T
    MULROONEY, R
    OSULLIVAN, DJ
    [J]. DIABETIC MEDICINE, 1990, 7 (07) : 580 - 584
  • [46] DETECTION AND TREATMENT OF SILENT-MYOCARDIAL-ISCHEMIA
    KOHYA, T
    YASUDA, H
    [J]. JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1992, 56 : 1491 - 1494
  • [47] EFFECT OF DILTIAZEM ON SILENT-MYOCARDIAL-ISCHEMIA
    ZHAROV, EI
    GALICHENKO, IV
    MARTYNOV, AI
    VERTKIN, AL
    STYROVA, TK
    [J]. KARDIOLOGIYA, 1991, 31 (10) : 15 - 17
  • [48] SILENT-MYOCARDIAL-ISCHEMIA - CLASSIFICATION AND MANAGEMENT
    COHN, PF
    [J]. HOSPITAL PRACTICE, 1990, 25 (2A): : 45 - &
  • [49] SILENT-MYOCARDIAL-ISCHEMIA IN ESRD PATIENTS
    CONLON, P
    KRUCOFF, M
    MINDA, SA
    MARTIN, G
    SCHWAB, SJ
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 440 - 440
  • [50] MEDICAL THERAPY FOR SILENT-MYOCARDIAL-ISCHEMIA
    PEPINE, CJ
    HILL, JA
    [J]. CIRCULATION, 1987, 75 (03) : 43 - 44